The pathogenesis of muscle pain
- PMID: 14604500
- DOI: 10.1007/s11916-003-0057-6
The pathogenesis of muscle pain
Abstract
Nociceptive nerve endings in muscles and other tissues are equipped with a multitude of receptor molecules for endogenous pain-producing and sensitizing agents. Particularly interesting molecules are the purinergic receptors, which can be activated by adenosine triphosphate (ATP), and the vanilloid receptor, which is sensitive to protons (low pH). The purinergic receptors are activated by tissue damage because cell necrosis is associated with the release of ATP. A low pH is present in many pathologic conditions such as ischemia and inflammation. At the spinal and medullar level, painful muscle lesions induce marked neuroplastic changes that result in hyperexcitability and hyperactivity of nociceptive neurons. This central sensitization is the basis for the spontaneous pain and hyperalgesia of patients. The transition from acute to chronic muscle pain is complete when the initially functional changes are transformed into structural ones. Patients with morphologic alterations in their nociceptive system are difficult to treat because the changes need time to normalize.
Similar articles
-
[Pathophysiology of low back pain and the transition to the chronic state - experimental data and new concepts].Schmerz. 2001 Dec;15(6):413-7. doi: 10.1007/s004820100002. Schmerz. 2001. PMID: 11793144 German.
-
Hypersensitivity in muscle pain syndromes.Curr Pain Headache Rep. 2003 Dec;7(6):426-32. doi: 10.1007/s11916-003-0058-5. Curr Pain Headache Rep. 2003. PMID: 14604501 Review.
-
Algesic agents exciting muscle nociceptors.Exp Brain Res. 2009 Jun;196(1):89-100. doi: 10.1007/s00221-008-1674-4. Epub 2009 Jan 13. Exp Brain Res. 2009. PMID: 19139871
-
[Functional neuroanatomy for pain stimuli. Reception, transmission, and processing].Schmerz. 2004 Jun;18(3):225-37. doi: 10.1007/s00482-003-0297-8. Schmerz. 2004. PMID: 15221425 German.
-
Mechanisms of pain in arthritis.Ann N Y Acad Sci. 2002 Jun;966:343-54. doi: 10.1111/j.1749-6632.2002.tb04234.x. Ann N Y Acad Sci. 2002. PMID: 12114291 Review.
Cited by
-
Advance in the mechanism and clinical research of myalgia in long COVID.Am J Clin Exp Immunol. 2024 Aug 25;13(4):142-164. doi: 10.62347/TXVO6284. eCollection 2024. Am J Clin Exp Immunol. 2024. PMID: 39310121 Free PMC article. Review.
-
A possible alternative to Opiorphin and its stable analogues for treating fibromyalgia pain: A clinical hypothesis.North Clin Istanb. 2023 Feb 20;10(1):122-126. doi: 10.14744/nci.2022.92603. eCollection 2023. North Clin Istanb. 2023. PMID: 36910437 Free PMC article. Review.
-
The transition of reported pain in different body regions--a one-year follow-up study.BMC Musculoskelet Disord. 2006 Feb 23;7:17. doi: 10.1186/1471-2474-7-17. BMC Musculoskelet Disord. 2006. PMID: 16504100 Free PMC article.
-
Botulinum toxin for pain.Drugs R D. 2008;9(1):11-27. doi: 10.2165/00126839-200809010-00002. Drugs R D. 2008. PMID: 18095750 Free PMC article. Review.
-
The Musculoskeletal Involvement After Mild to Moderate COVID-19 Infection.Front Physiol. 2022 Mar 18;13:813924. doi: 10.3389/fphys.2022.813924. eCollection 2022. Front Physiol. 2022. PMID: 35492595 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical